Leviticus Partners LP 13D and 13G filings for Applied DNA Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-07 10:11 am Sale |
2024-10-30 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 0 0.000% |
-1,333 (Position Closed) |
Filing |
| 2024-10-02 4:38 pm Purchase |
2024-10-01 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 1,333 9.710% |
1,333 (New Position) |
Filing |
| 2024-08-19 12:12 pm Sale |
2024-08-19 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 0 0.000% |
-1,155 (Position Closed) |
Filing |
| 2024-08-09 09:28 am Purchase |
2024-08-08 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 1,155 8.410% |
289 (+33.35%) |
Filing |
| 2024-06-24 11:44 am Purchase |
2024-06-20 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 866 7.210% |
105 (+13.76%) |
Filing |
| 2024-06-03 12:23 pm Purchase |
2024-05-28 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 762 5.590% |
655 (+614.04%) |
Filing |
| 2024-05-01 5:38 pm Purchase |
2024-04-25 | 13G | Applied DNA Sciences, Inc. APDN |
Leviticus Partners LP | 107 9.270% |
107 (New Position) |
Filing |